DRMA icon

Dermata Therapeutics
DRMA

7 hedge funds and large institutions have $62.4K invested in Dermata Therapeutics in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

87% less capital invested

Capital invested by funds: $463K → $62.4K (-$401K)

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$55.5K
2
+$11.3K
3
+$7.85K
4
TRCT
Tower Research Capital (TRC)
New York
+$5.14K
5
JP Morgan Chase
JP Morgan Chase
New York
+$2.27K

Top Sellers

1
-$410K
2
-$28.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
1
Clear Street
New York
$39.4K
Bank of America
2
Bank of America
North Carolina
$8.02K
Barclays
3
Barclays
United Kingdom
$5.57K
TRCT
4
Tower Research Capital (TRC)
New York
$4.64K
UBS Group
5
UBS Group
Switzerland
$2.87K
JP Morgan Chase
6
JP Morgan Chase
New York
$1.61K
SS
7
SBI Securities
Japan
$234
AC
8
Armistice Capital
New York
–